Eye fluid study seeks clues to untreatable blindness
NCT ID NCT03418220
First seen Jan 10, 2026 · Last updated May 22, 2026 · Updated 22 times
Summary
This study looked at 82 patients with age-related macular degeneration (AMD) to measure inflammation markers in the fluid of their eyes. The goal was to find specific markers that could help explain the dry form of AMD, for which there is no treatment. By comparing these markers between different AMD types and healthy controls, researchers hope to identify targets for future therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MACULAR DEGENERATION, AGE-RELATED are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital de la Croix-Rousse
Lyon, 69004, France
Conditions
Explore the condition pages connected to this study.